Le Lézard
Classified in: Health
Subjects: VET, ATY

US Navy Veterans Mesothelioma Has Endorsed the Remarkable Legal Team at Danziger & De Llano for a Navy Submarine Veteran with Recently Diagnosed Mesothelioma Anywhere in the USA-Compensation Might be Millions of Dollars


WASHINGTON, July 7, 2022 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate is the top branded source in the nation for Navy Veterans with recently diagnosed mesothelioma and their number one priority for people like this is they receive the best compensation results-especially if they served on a submarine. Financial compensation for a Navy Submarine Veteran might be in the millions of dollars.

To get the financial compensation done for a person like this the Advocate has endorsed and they recommend the remarkable legal team at the law firm of Danziger & De Llano. The lawyers at Danziger & De Llano have been assisting Navy Veterans with financial compensation for over two decades and they deliver superior results nationwide as they are always happy to discuss at 800-864-4000. https://meso.dandell.com

The Advocate says, "If a Navy Veteran who now has mesothelioma anywhere in the USA would like to receive the very best possible financial compensation results it is vital, they or their family hire a lawyer that knows what they are doing--especially if the person is a Submarine Veteran. With the law firm of Danziger & De Llano you will get a very skilled team of lawyers who know exactly what they are doing. Before a Navy Submarine Veteran with mesothelioma anywhere in the nation or their family hire an attorney to assist with compensation-please call the remarkable legal team at Danziger & De Llano at 800-864-4000. We are confident you will be glad you did." https://meso.dandell.com

Types of US Navy Nuclear Submarines from the US Navy Veterans Mesothelioma Advocate:

US Navy Submarine Bases are situated in the following states: Connecticut-New London, Washington-Navy Base Kitsap, Georgia-Naval Submarine Base Kings Bay, Virginia-Navy Station Norfolk, Hawaii-Naval Station Pearl Harbor, California-Naval Base Point Loma. 

According to the CDC the states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

However, based on the calls the US Navy Veterans Mesothelioma Advocate receives a US Navy Veteran who has been diagnosed with mesothelioma could live in any state including New York, Florida, California, Texas, Ohio, Iowa, Indiana, Missouri, North Carolina, Kentucky, Tennessee, Georgia, Alabama, Oklahoma, Arkansas, Kansas, Nebraska, North Dakota, Wyoming, Nevada, Colorado, New Mexico, Utah, Arizona, Idaho, or Alaska. https://meso.dandell.com

For more information about mesothelioma, please refer to the National Institutes of Health's web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Contact:
Michael Thomas
202-422-2069
[email protected]

SOURCE US Navy Veterans Mesothelioma Advocate


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: